All mutation analyzes of the most common tumors that have been done abroad so far and that have been waiting for a long time, will be done at the Clinical Center of Montenegro (KCCG) from June 1, and the findings will be ready in a few days.
The Clinical Center clarified that the PCR laboratory of the Clinical Center of Montenegro, which functions within the Center for Pathology, will be given a new purpose.
"Since we have completed the reconstruction of the appropriate part of the Center for Pathology, we will be doing a series of new analyzes here from June 1, 2022. These are, for example, determination of mutations within tumors, screening program for early detection of cervical cancer, cystic fibrosis analyses, analyzes for the HIV virus, sexually transmitted diseases, PAPA tests...", announced the director of KCCG Ljiljana Radulović.
She added that the space is equipped, and that their staff had previously completed all training. As they said from that health institution, it is expected that slightly more than 500 PCR analyzes are performed in this laboratory per day.
"Given that the Center for Pathology of the Clinical Center of Montenegro is the base of the Faculty of Medicine in Podgorica, we are looking forward to enabling our colleagues to participate in a large number of scientific research projects," stressed Radulović.
Director of the Center for Pathology, Filip Vukmirović, explained that molecular analysis of tumor tissue will be performed in the laboratory, which is necessary for us in modern medicine in order to be able to adequately treat tumors.
"In fact, revolutionary changes have taken place in oncology. Today, we have targeted therapy, that is, targeted drugs or so-called smart drugs for certain malignant tumors. And in order to be able to apply these drugs, we need to find the antigen inside the tumor cells to which these drugs bind. In this way, with the analyzes that we are introducing in KCCG, we will make it possible primarily for the most common tumors, such as lung tumors, colon tumors and breast tumors, to determine early the so-called "driver" mutations that can be influenced and where patients with such mutations can be treated very successfully with modern therapy. Until now, these analyzes for patients were performed outside of Montenegro, and by putting three PCR machines into operation, we will be able to perform such analyses, as well as a number of new analyses, here in our Center," said Vukmirović.
"This means that from now on, our patients will have all the findings, which they have been waiting for a long time, within a few days. "We will quickly provide our oncologists with important information that is essential for determining therapy," he added.
Mileta Golubović, head of the Department of Pathohistology, said that this laboratory is the product of a burning desire to provide our patients with state-of-the-art diagnostics.
"Analyses will be performed on biopsy pathohistological material of various types of tumors. The center for pathology performs an extremely large number of analyzes of lung, breast, melanoma, digestive, gynecological, urological, head and neck tumors. Even based on the sample, the so-called "liquid biopsy" can obtain certain tumor products. "The modern concept increasingly emphasizes that the essence of adequate treatment of tumors is the detection of its genetic profile and its potential to damage the patient's health or life," explained Golubović.
"The imperative of modern medicine is to approach each patient individually. It is a personalized or individualized diagnosis. Such diagnostics implies personalized and individualized therapy of patients. This means that we will have adequate weapons in the fight against terrible scourges such as malignancies," Golubović added.
In addition, he pointed out, the laboratory will enable the strengthening of the position and role of KCCG and the entire health system in the upcoming period.
"This laboratory allows us to meet events in the most adequate way. In this way, we will stand in line with the most organized and developed health systems in the world", believes Golubović.
Bonus video:
